Johnson & Johnson Stock News

Booster shots were authorized by the Food and Drug Administration on Friday for every American 18 and older who has received a Pfizer-BioNTech or Moderna vaccine. Recipients of the Johnson & Johnson vaccine already had been cleared for boosters.

The United States, through the COVID-19 Vaccines Global Access (COVAX) facility, delivered 580,320 Pfizer COVID-19 vaccine doses to the people of Zambia. This is the first delivery of Pfizer vaccine doses to Zambia following four successful deliveries of the Johnson & Johnson (J&J) vaccine. This latest delivery brings the total number of vaccines provided by []

Tarbox Family Office Inc. trimmed its stake in shares of Johnson & Johnson (NYSE:JNJ) by 0.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,042 shares of the companys stock after selling 69 shares during the quarter. Tarbox Family Office Inc.s holdings in []

The Supreme Court has agreed to take on a case involving the Clean Air Act. The post Legal Roundup: Johnson & Johnson Settles Suit, Clean Air Act Reaches Supreme Court and More appeared first on Risk & Insurance .

Mark Pukita''s Senate financial disclosures indicate he holds up to $50,000 in Johnson & Johnson stock and up to $15,000 in Pfizer stock.

Currently, the vaccines approved by the Ministry of Public Health of Qatar include Pfizer, Moderna, AstraZeneca, and Johnson&Johnson

Symphony Financial Ltd. Co. decreased its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 21.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,442 shares of the companys stock after selling 1,733 shares during the period. Symphony Financial Ltd. []

WASHINGTON, D. C.: The United States authorized the Pfizer and Moderna Covid vaccine boosters for all people aged 18 and older on Friday as the world''s hardest-hit country enters a new winter wave of the pandemic. Boosters were previously available to the immune compromised, people over 65, those at high risk of severe disease and people in high risk occupations. The new decision "helps to provide continued protection against Covid-19, including the serious consequences that can occur, such as hospitalization and death," acting commissioner Janet Woodcock of the Food and Drug Administration (FDA) said. A panel of experts convened by the Centers for Disease Control and Prevention (CDC) then ratified the decision to broaden eligibility, while explicitly recommending boosters for all people over 50, even absent underlying conditions. "I am really glad that we have clarity and streamlining of the recommendations so that all Americans can understand the vaccines that are recommended for them at this time," said Camille Kotton, an infectious disease clinician at Massachusetts General Hospital.

The FDA amended emergency use authorizations (EUAs) for the Moderna Inc. COVID-19 vaccine as well as the shot from Pfizer Inc. and Biontech SE. A single booster dose was green-lighted for people 18 years and older at least six months after finishing the primary regimen with either of the vaccines, or at least two months after getting the Johnson & Johnson shot.

NEW YORK: The US Food and Drug Administration on Friday authorized booster doses of COVID-19 vaccines for all adults who were vaccinated with the Pfizer Inc and partner BioNTech SE shot and the Moderna Inc shot. The regulators decision paves the way for millions of Americans to get additional protection and is aimed at addressing waning protection among fully vaccinated Americans in the face of Delta variant-driven breakthrough cases of the illness. The FDA authorization paves the way for all adults who had their second dose of Pfizer/BioNTech or Moderna six months prior, as well as those who had the Johnson & Johnson Inc. shot 2 months ago, to get a booster dose in the United States. The final regulatory review moves to a meeting of an advisory committee to the Centers for U.S. Disease Control and Prevention (CDC) on boosters scheduled for noon on Friday, and then a recommendation from the agencys director, who has publicly supported boosters for all. Over 31 million Americans have already received a booster shot, but current CDC guidelines recommend extra doses only for some population groups.

The Delaware Division of Public Health (DPH) is advising all fully vaccinated Delawareans 18 and older to get a booster dose of Pfizer, Moderna, or Johnson & Johnson Covid-19 vaccines. Originally, eligibility was limited to individuals 65 and older and those 18-64 with underlying health conditions or occupational or residential risks of exposure to Covid-19. Booster [] The post Division of Public Health advises vaccinated adults to get Covid booster appeared first on Delaware Business Now .

Related Stocks: AAPL , IVV , SCHA , JNJ , SHW , SPY , PTLC , SPLG , ESGU , VUG , EFV , EFG , SCHX , SCHG , SCHZ , SCHF , VYM , SCHM ,

Apexium Financial LP lifted its position in Johnson & Johnson (NYSE:JNJ) by 8.3% during the third quarter, HoldingsChannel.com reports. The fund owned 1,965 shares of the companys stock after purchasing an additional 150 shares during the period. Apexium Financial LPs holdings in Johnson & Johnson were worth $317,000 at the end of the most recent []

LAKE COUNTY, Calif. The Lakeport City Council this week voted to take action on two cases of litigation as part of seeking settlements for the impact of the opioid crisis on the city and its residents. Following the open session of its regular Tuesday night meeting, the council went into a nearly hourlong closed session just before 6:45 p.m. to discuss the citys lawsuit against opioid distributor AmerisourceBergen Drug Corp. as well as another potential case of litigation. When the council emerged shortly after 7:35 p.m., City Attorney David Ruderman said the council had voted 5-0 to approve a settlement with McKesson, AmerisourceBergen, Cardinal Health and Janssen, also known as Johnson & Johnson, regarding the citys lawsuit against them related to their contribution to the opioid epidemic. The city reported that the settlement will provide up to $2.263 billion to California and its 431 eligible counties and cities. On July 21, several states attorneys general, including Californias, entered into a $26 billion settlement with Cardinal, McKesson and AmerisourceBergen the nations three major pharmaceutical distributors and Johnson & Johnson, which manufactured and marketed opioids.